Lee Ji-Hyun, Jo Eun Hee, Lee Bori, Noh Hyeon Min, Park Sunggu, Lee Young-Mi, Kim Dae-Ki, Park Min Chel
Department of Immunology and Institute of Medical Sciences, Medical School, Chonbuk National University, Jeonju, South Korea.
Research Center of Traditional Korean Medicine, Wonkwang University, Iksan, South Korea.
Front Pharmacol. 2019 Jul 3;10:742. doi: 10.3389/fphar.2019.00742. eCollection 2019.
(SST) is a well-known traditional herbal medicine used for the treatment of many diseases. The aims of this study are to investigate the effects of SST on atopic dermatitis (AD) symptoms and to examine its mechanism. Human keratinocyte (HaCaT) cells were stimulated with tumor necrosis factor alpha (TNF-α)/IFN-γ to induce AD-like keratinocyte environment. 2,4-Dinitrochlorobenzene (DNCB) was used to induce AD-like skin lesions in the dorsal skin of BALB/c mice. SST and dexamethasone were administered orally for 14 day. As a result, SST treatment increased the expression of heme oxygenase-1 (HO-1), an anti-oxidative factor, and the nuclear translocation of NF-E2 p45-related factor 2 (Nrf2). In addition, the treatment also decreased the expression level of inflammatory mediator nuclear factor-κB (NF-κB) and the adhesion molecule intercellular adhesion molecule-1 (ICAM-1). SST treatment (75 and 150 mg/kg) significantly relieved AD symptoms in DNCB-induced AD-like mice by restoring skin thickness, spleen weight, immunoglobulin E (IgE), interleukin 4 (IL-4), pro-inflammatory cytokine expression, and expression of several other mediators. We found that SST alleviates AD-like skin lesions and skin inflammation by modulating various atopic symptoms and inflammatory mediators. Therefore, SST can be used as an alternative drug for the treatment of AD.
(SST)是一种用于治疗多种疾病的著名传统草药。本研究的目的是研究SST对特应性皮炎(AD)症状的影响并探讨其作用机制。用人角质形成细胞(HaCaT)细胞与肿瘤坏死因子α(TNF-α)/干扰素-γ刺激以诱导类似AD的角质形成细胞环境。用2,4-二硝基氯苯(DNCB)诱导BALB/c小鼠背部皮肤出现类似AD的皮肤损伤。口服给予SST和地塞米松14天。结果,SST治疗增加了抗氧化因子血红素加氧酶-1(HO-1)的表达以及NF-E2 p45相关因子2(Nrf2)的核转位。此外,该治疗还降低了炎症介质核因子-κB(NF-κB)和黏附分子细胞间黏附分子-1(ICAM-1)的表达水平。SST治疗(75和150mg/kg)通过恢复皮肤厚度、脾脏重量、免疫球蛋白E(IgE)、白细胞介素4(IL-4)、促炎细胞因子表达以及其他几种介质的表达,显著缓解了DNCB诱导的类似AD小鼠的AD症状。我们发现SST通过调节各种特应性症状和炎症介质来减轻类似AD的皮肤损伤和皮肤炎症。因此,SST可作为治疗AD的替代药物。